BMRA - Biomerica gets notice of allowance for new patent in Canada

Biomerica (NASDAQ:BMRA) announces that the Canadian Patent Office has issued a notice of allowance for the company's patent application related to its InFoods diagnostic guided therapy platform technology. The technology offers a novel approach in the treatment of patients suffering from Irritable Bowel Syndrome (IBS). The allowed patent contains claims that broadly cover a method that enables physicians to identify patient-specific foods, that, when removed from the patient’s diet, may alleviate or improve an individual’s IBS symptoms. Shares down more than 2% premarket.

For further details see:

Biomerica gets notice of allowance for new patent in Canada